Micropenis and the 5α-reductase-2 (SRD5A2) gene:: Mutation and V89L polymorphism analysis in 81 Japanese patients

被引:53
|
作者
Sasaki, G
Ogata, T
Ishii, T
Kosaki, K
Sato, S
Homma, K
Takahashi, T
Hasegawa, T
Matsuo, N
机构
[1] Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo 1608582, Japan
[2] Natl Res Inst Child Hlth & Dev, Tokyo 1548567, Japan
[3] Saitama Municipal Hosp, Dept Pediat, Saitama 3368522, Japan
[4] Keio Univ, Sch Med, Dept Lab Med, Tokyo 1608582, Japan
[5] Natl Ctr Child Hlth & Dev, Tokyo 1578535, Japan
来源
关键词
D O I
10.1210/jc.2002-021415
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 5alpha-reductase-2 encoded by the SRD5A2 gene plays a critical role in male sex differentiation by converting testosterone into 5alpha dihydrotestosterone in the peripheral target tissues. In this study, we examined the SRD5A2 gene in 81 Japanese patients with micropenis (age, 0-14 yr; median, 7 yr) whose stretched penile lengths were between -2.5 SD and -2.0 SD in 39 patients (age, 0-13 yr; median, 8 yr) and below -2.5 SD in 42 patients (age, 0-14 yr; median, 6 yr), together with 100 control males (50 boys and 50 fertile adult males). Mutation analysis was performed for exons 1-5 and their flanking introns by denaturing HPLC and direct sequencing, revealing Y26X/R227Q in an 11-yr-old boy with a penile length of -2.6 SD, G34R/R227Q in a 9-yr-old boy with a penile length of -3.6 SD, and R227Q/R227Q in a 3-yr-old boy with a penile length of -2.4 SD, together with heterozygous R227Q in a control boy and a fertile adult male. Polymorphism analysis was carried out for the most frequent V89L known to reduce the enzyme activity by approximately 30% in 78 patients, except for the three patients with SRD5A2 mutations, and in the 100 control males by direct sequencing, showing that allele and genotype frequencies were similar between 78 patients with micropenis below -2.0 SD or 40 patients with micropenis below -2.5 SD and the 100 control males, the 50 boys, or the 50 fertile adult males, with no statistically significant differences. The results suggest that, in Japanese patients, micropenis can be caused by SRD5A2 gene mutations, especially by R227Q which has been shown to retain approximately 3.2% of normal enzyme activity and appears relatively frequent in Asian populations, and that V89L polymorphism is unlikely to raise the susceptibility to the development of micropenis.
引用
收藏
页码:3431 / 3436
页数:6
相关论文
共 50 条
  • [31] The Association of SRD5A2 Gene Polymorphism at Codon 89 and Prostate Cancer Risk: Case Control Study
    Dusenka, R.
    Tomaskin, R.
    Grobarcikova, S.
    Sivonova, Kmetova M.
    Dobrota, D.
    Kliment, J.
    UROLOGY, 2012, 80 (03) : S82 - S83
  • [32] Association of 5-alpha-reductase gene (SRD5A2) with prostate cancer.
    Mononen, N
    Koivisto, PA
    Ikonen, T
    Syrjäkoski, K
    Schleutker, J
    Hyytinen, E
    Tammela, TLJ
    Kallioniemi, OP
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 95 - 95
  • [33] Testosterone enanthate therapy is effective and independent of SRD5A2 and AR gene polymorphisms in boys with micropenis
    Ishii, T
    Sasaki, G
    Hasegawa, T
    Sato, S
    Matsuo, N
    Ogata, T
    JOURNAL OF UROLOGY, 2004, 172 (01): : 319 - 323
  • [34] Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency
    Marzuki, Nanis S.
    Idris, Firman P.
    Kartapradja, Hannie D.
    Harahap, Alida R.
    Batubara, Jose R. L.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2019, 2019
  • [35] Association of V89L SRD5A polymorphism and prostate cancer development in a Japanese population (vol 169 pg 2378, 2002)
    Kinoshita, H
    JOURNAL OF UROLOGY, 2003, 170 (05): : 1957 - 1957
  • [36] Identification of three novel SRD5A2 mutations in Chinese patients with 5α-reductase 2 deficiency
    Cheng, Tong
    Wang, Hao
    Han, Bing
    Zhu, Hui
    Yao, Hai-Jun
    Zhao, Shuang-Xia
    Zhu, Wen-Jiao
    Zhai, Hua-Ling
    Chen, Fu-Guo
    Song, Huai-Dong
    Cheng, Kai-Xiang
    Liu, Yang
    Qiao, Jie
    ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (06) : 577 - +
  • [37] Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk:: An explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors
    Cussenot, Oliuier
    Azzouzi, Abdel-Rahmene
    Nicolaiew, Nathalie
    Mangin, Philippe
    Cormier, Luc
    Fournier, Georges
    Valeri, Antoine
    Cancel-Tassin, Geraldine
    EUROPEAN UROLOGY, 2007, 52 (04) : 1082 - 1089
  • [38] V89L(rs523349) and A49T(rs9282858) variations on SRD5A2 gene on dutasteride efficacy and safety in bladder cancer patients: A pilot study
    Incir, C.
    Gumustekin, M.
    Korhan, P.
    Ozer, M.
    Sarikaya, A.
    Bozkurt, O.
    Atabey, N.
    Esen, A.
    Tuncok, Y.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S99 - S100
  • [39] Try235Phe homozygous mutation of the steroid 5-a reductase type 2 (SRD5A2) gene in a Turkish patient
    Parlak, Mesut
    Durmaz, Erdem
    Gursoy, Semin
    Bircan, Iffet
    Akcurin, Sema
    ANNALS OF SAUDI MEDICINE, 2014, 34 (03) : 254 - 256
  • [40] Male pseudohermaphroditism resulting from a novel mutation in the human steroid 5 alpha-reductase type 2 gene (SRD5A2)
    Anwar, R
    Gilbey, SG
    New, JP
    Markham, AF
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1997, 50 (01): : 51 - 52